BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27864071)

  • 1. Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT
    Schrader TO; Kasem M; Ren A; Feichtinger K; Al Doori B; Wei J; Wu C; Dang H; Le M; Gatlin J; Chase K; Dong J; Whelan KT; Sage C; Grottick AJ; Semple G
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5877-5882. PubMed ID: 27864071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT
    Schrader TO; Zhu X; Kasem M; Ren A; Liu C; Wu C; Dang H; Le M; Gatlin J; Chase K; Frazer J; Whelan KT; Grottick AJ; Hutton C; Barden J; Chen C; Ortiz A; Feichtinger K; Semple G
    Bioorg Med Chem Lett; 2021 Apr; 38():127872. PubMed ID: 33636307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Discovery of Functionally Selective Serotonin 2C (5-HT
    Cheng J; McCorvy JD; Giguere PM; Zhu H; Kenakin T; Roth BL; Kozikowski AP
    J Med Chem; 2016 Nov; 59(21):9866-9880. PubMed ID: 27726356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.
    Cheng J; Giguère PM; Onajole OK; Lv W; Gaisin A; Gunosewoyo H; Schmerberg CM; Pogorelov VM; Rodriguiz RM; Vistoli G; Wetsel WC; Roth BL; Kozikowski AP
    J Med Chem; 2015 Feb; 58(4):1992-2002. PubMed ID: 25633969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT
    Kim J; Kim YJ; Londhe AM; Pae AN; Choo H; Kim HJ; Min SJ
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31491978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
    Cheng J; Kozikowski AP
    ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a lead series of potent benzodiazepine 5-HT
    Ren A; Zhu X; Feichtinger K; Lehman J; Kasem M; Schrader TO; Wong A; Dang H; Le M; Frazer J; Unett DJ; Grottick AJ; Whelan KT; Morgan ME; Sage CR; Semple G
    Bioorg Med Chem Lett; 2020 Mar; 30(5):126929. PubMed ID: 31952960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT
    Carpenter J; Wang Y; Wu G; Feng J; Ye XY; Morales CL; Broekema M; Rossi KA; Miller KJ; Murphy BJ; Wu G; Malmstrom SE; Azzara AV; Sher PM; Fevig JM; Alt A; Bertekap RL; Cullen MJ; Harper TM; Foster K; Luk E; Xiang Q; Grubb MF; Robl JA; Wacker DA
    J Med Chem; 2017 Jul; 60(14):6166-6190. PubMed ID: 28635286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective 5-HT2C receptor agonists: Design and synthesis of pyridazine-fused azepines.
    Green MP; McMurray G; Storer RI
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4117-21. PubMed ID: 27381086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New halogenated tris-(phenylalkyl)amines as h5-HT2B receptor ligands.
    Kapadia N; Ahmed S; Harding WW
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3216-3219. PubMed ID: 27261181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel 1-
    Mao Q; Zhang B; Li W; Tian S; Shui W; Ye N
    ACS Chem Neurosci; 2020 Feb; 11(4):549-559. PubMed ID: 31968160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists.
    Huck BR; Llamas L; Robarge MJ; Dent TC; Song J; Hodnick WF; Crumrine C; Stricker-Krongrad A; Harrington J; Brunden KR; Bennani YL
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2891-4. PubMed ID: 16546379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amberlyst-15 catalysed synthesis of novel indole derivatives under ultrasound irradiation: Their evaluation as serotonin 5-HT
    Reddy GS; Kamaraj R; Hossain KA; Kumar JS; Thirupataiah B; Medishetti R; Sushma Sri N; Misra P; Pal M
    Bioorg Chem; 2021 Nov; 116():105380. PubMed ID: 34670330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.
    Gannon BM; Sulima A; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.
    Higgins GA; Silenieks LB; Lau W; de Lannoy IA; Lee DK; Izhakova J; Coen K; Le AD; Fletcher PJ
    Psychopharmacology (Berl); 2013 Apr; 226(3):475-90. PubMed ID: 23184281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.
    Fevig JM; Feng J; Rossi KA; Miller KJ; Wu G; Hung CP; Ung T; Malmstrom SE; Zhang G; Keim WJ; Cullen MJ; Rohrbach KW; Qu Q; Gan J; Pelleymounter MA; Robl JA
    Bioorg Med Chem Lett; 2013 Jan; 23(1):330-5. PubMed ID: 23177783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonists.
    Hudson AR; Higuchi RI; Roach SL; Adams ME; Vassar A; Syka PM; Mais DE; Miner JN; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1697-700. PubMed ID: 21316964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders.
    Tye H; Mueller SG; Prestle J; Scheuerer S; Schindler M; Nosse B; Prevost N; Brown CJ; Heifetz A; Moeller C; Pedret-Dunn A; Whittaker M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):34-7. PubMed ID: 21146986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.